$CureVac (CVAC.US)$CureVac Announced The Latest Trial Dates For Its Ongoing Patent Litigation Against Pfizer/BioNTech In Multiple Geographies, Including The U.S., UK, And Germany Benzinga· 1 min ago New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics. First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
CureVac股票討論
CureVac 將癌症疫苗候選人 CVGBM 推進第一階段研究的 B 部分
經切除術的膠質細胞瘤患者
· 第一位患者接種以 MRNA 為基礎的多表性癌症候選人 cVGBM 的第一個患者進行第一階段測試劑量確認第 b 部分
· B 部分預計將包括多達 20 名患者,以產生有關安全性,耐受性的擴展數據
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
暫無評論